REZO THERAPEUTICS
Live / Allowed — Fourth extension granted (statement of use) (as of 15 May 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 23 Nov 2022 filing date already counts against anyone who files later.
Record
- Serial number
- 97690237
- Mark type
- Word mark
- Filed
- 23 Nov 2022
- Published for opposition
- 16 Apr 2024
- Attorney of record
- Brendan J. Hughes
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and substances for use in the field of oncology
- Class 042 — Scientific and technological services: Research and development in the pharmaceutical and biotechnology fields; providing medical and scientific search information in the fields of pharmaceuticals and genetics
Owner
- Rezo Therapeutics, Inc., South San Francisco, CA, US
- Rezo Therapeutics, Inc., South San Francisco, CA, US
Prosecution history
- 16 May 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 15 May 2026 — SOU EXTENSION 4 GRANTED
- 15 May 2026 — SOU EXTENSION 4 FILED
- 15 May 2026 — SOU TEAS EXTENSION RECEIVED
- 28 Oct 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 27 Oct 2025 — SOU EXTENSION 3 GRANTED
- 27 Oct 2025 — SOU EXTENSION 3 FILED
- 27 Oct 2025 — SOU TEAS EXTENSION RECEIVED
- 07 May 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 07 May 2025 — SOU EXTENSION 2 GRANTED
- 06 May 2025 — SOU EXTENSION 2 FILED
- 06 May 2025 — SOU TEAS EXTENSION RECEIVED
- 03 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 04 Dec 2024 — SOU EXTENSION 1 GRANTED
- 03 Dec 2024 — SOU EXTENSION 1 FILED